Last reviewed · How we verify
NCT05725330
The Effect of Gamification on Patients With Type 2 Diabetes
NA trial testing Gamification and education with mobile game application in Gamification in 88 participants. Status unknown.
17 September 2023
Quick facts
| Lead sponsor | Sakarya University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 88 |
| Start date | 25 February 2023 |
| Primary completion | 17 September 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Gamification and education with mobile game application
Conditions studied
- Gamification — all drugs for Gamification →
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
- Self-management — all drugs for Self-management →
- Digital Health — all drugs for Digital Health →
Sponsor
Sakarya University
Who can join
Adults 18 to 65, any sex, with Gamification or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Diabetes is a broad-spectrum metabolic disorder that causes a defect in the organism's carbohydrate, fat, and protein metabolism processes due to insulin deficiency or impaired insulin effect. Diabetes requires continuous medical care and causes chronic, severe mortality and morbidity. More than 90% of all people with diabetes worldwide suffer from Type 2 DM. Diabetes self-management includes self-monitoring of blood glucose levels, knowing and managing the symptoms of hypoglycemia and hyperglycemia, adherence to diet, physical exercise, and diabetic foot care. Considering the high prevalent and undesirable consequences of diabetes in the world, it is necessary to benefit from new educational technologies and tools. One of these technologies is gamification, which increases the quality of education as an effective educational tool, creates motivation and enthusiasm, and develops a sense of competition in the target audience. This study plans to develop a game that will include virtual coaching to increase the self-management and glycemic control of patients with type 2 diabetes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05725330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gamification
Currently open trials in the same condition.
- NCT07229573 — The Effectiveness of Serious Game-Based Training for Nursing Students in Postpartum Haemorrhage Management · NA · recruiting
- NCT07039851 — CreativeDrama and GamificationBased · NA · recruiting
- NCT06402942 — Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy · NA · recruiting
- NCT07125131 — Gamification-Enhanced Problem-Based Learning · NA · recruiting
- NCT06714474 — Effectiveness of Virtual Simulation Game in Teaching Venous Blood Sampling Skills to Nursing Students · NA · recruiting
Other Sakarya University trials
Trials by the same sponsor.
- NCT07467655 — THE EFFECT OF DIGITAL STORYTELLING ON NURSING STUDENTS' NURSING PROCESS EDUCATION · NA · not yet recruiting
- NCT07508579 — Effect of Hypothermia on BIS and PSI Correlation During Cardiopulmonary Bypass · not yet recruiting
- NCT07537335 — Knee Osteoartritis Genicular Nerve RF Ablation vs Alcohol Neurolysis · NA · not yet recruiting
- NCT07533669 — Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients · NA · not yet recruiting
- NCT07487324 — Oxygenation in Posterior Stabilization Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05725330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sakarya University
- Last refreshed: 13 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05725330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing